THYROID-HORMONES AND DEPRESSIVE-ILLNESS - IMPLICATIONS FOR CLINICAL AND BASIC RESEARCH

被引:0
|
作者
BAUMGARTNER, A [1 ]
CAMPOSBARROS, A [1 ]
MEINHOLD, H [1 ]
机构
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,NUKL MED RADIOCHEM ABT,W-1000 BERLIN 45,GERMANY
关键词
THYROID HORMONES; IODOTHYRONINE; DEIODINASES; CENTRAL NERVOUS SYSTEM; DEPRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been well-known for at least 100 years that both hypo- and hyperthyroidism may cause almost any psychiatric symptom, depending on the severity of the illness. No thyroid disorder, however, induces symptoms that are specific for a psychiatric disorder. Laboratory tests show depressed patients to be euthyroid. Any abnormalities that have been found, such as slightly elevated T4 levels or decreased T3 or TSH concentrations, have frequently failed to be replicated and do not fit any endocrinological diagnosis. They could reflect either "intervening factors" such as stress, methodological problems or a disturbance of central thyroid hormone metabolism. All antidepressant therapies (antidepressant drugs, carbamazepine, lithium, electroconvulsive therapy and sleep deprivation) have a marked influence on peripheral thyroid hormone levels. In particular, decreases in serum T4 and rT3 levels are often correlated to antidepressant response, suggesting that an effect on central thyroid hormone metabolism is involved in the as yet unknown mechanism of action of these therapies. Indeed, animal studies have shown that antidepressants do affect deiodinase activities and T3 and T4 concentrations in rat brain. However, the effects are highly area specific and dependent on the drug administered and the time of day at which the investigation was conducted. Although the mechanism of thyroid hormone action on CSF signal transduction is as yet unknown, effects on "general CNS functions" such as second messengers, G-proteins or calcium homeostasis seem more likely than specific effects on the different receptor systems.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 50 条
  • [21] THE DEXAMETHASONE SUPPRESSION TEST IN DEPRESSIVE-ILLNESS - CLINICAL CORRELATES
    ASNIS, GM
    HALBREICH, U
    NATHAN, RS
    OSTROW, L
    NOVACENKO, H
    ENDICOTT, J
    SACHAR, EJ
    PSYCHONEUROENDOCRINOLOGY, 1982, 7 (04) : 295 - 301
  • [22] THYROIDAL AND PERIPHERAL PRODUCTION OF THYROID-HORMONES - REVIEW OF RECENT FINDINGS AND THEIR CLINICAL IMPLICATIONS
    SCHIMMEL, M
    UTIGER, RD
    ANNALS OF INTERNAL MEDICINE, 1977, 87 (06) : 760 - 768
  • [23] METABOLISM OF THYROID-HORMONES AND ITS CLINICAL APPLICATIONS
    MORNEX, R
    PIGEON, P
    REVUE DU PRATICIEN, 1979, 29 (11): : 979 - +
  • [24] DETERMINATION OF THYROID-HORMONES ANTIBODIES AND THEIR CLINICAL RELEVANCE
    TEUBER, J
    HELMKE, K
    MASER, E
    GREBE, S
    FEDERLIN, K
    IMMUNITAT UND INFEKTION, 1981, 9 (01): : 12 - 19
  • [25] THE CLINICAL-PHARMACOLOGY OF THYROID-HORMONES IN THE DOG
    EVINGER, JV
    NELSON, RW
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1984, 185 (03) : 314 - 316
  • [26] THYROID-HORMONES AND THYROID RESERVE IN PRE-CLINICAL HYPOTHYROIDISM
    NOELPP, B
    STAUB, JJ
    HEINIMANN, T
    GRANI, R
    GIRARD, J
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 111 (49) : 1904 - 1905
  • [27] GABA UPTAKE IS INHIBITED BY THYROID-HORMONES - IMPLICATIONS FOR DEPRESSION
    MASON, GA
    WALKER, CH
    PRANGE, AJ
    BONDY, SC
    PSYCHONEUROENDOCRINOLOGY, 1987, 12 (01) : 53 - 59
  • [28] CLINICAL EFFECTS OF SEROTONIN REUPTAKE INHIBITORS IN THE TREATMENT OF DEPRESSIVE-ILLNESS
    BURROWS, GD
    MCINTYRE, IM
    JUDD, FK
    NORMAN, TR
    JOURNAL OF CLINICAL PSYCHIATRY, 1988, 49 : 18 - 22
  • [29] METHODOLOGIC AND CLINICAL ASPECTS OF FREE THYROID-HORMONES ASSAY
    HERMANS, J
    BALDEWYNS, P
    BEAUDUIN, M
    JOURNAL DE BIOPHYSIQUE & MEDECINE NUCLEAIRE, 1984, 8 (04): : 235 - 238
  • [30] CLINICAL MANIFESTATIONS OF DEPRESSIVE-ILLNESS WITH ABNORMAL ACETYL METHYL CARBINOL METABOLISM
    ANDERSON, WM
    DAWSON, J
    JOURNAL OF MENTAL SCIENCE, 1962, 108 (452): : 80 - &